The Angelman Syndrome Foundation Company Profile

11:49 EDT 18th March 2018 | BioPortfolio

News Articles [995 Associated News Articles listed on BioPortfolio]

Agilis Presents Data from its Gene Therapy Program for Angelman Syndrome

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nerv...

Agilis Biotherapeutics Announces Presentations on Angelman Syndrome Program at ESGCT and NORD ...


Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Angelman Syndrome

NEW YORK, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurol...

Agilis Biotherapeutics Announces Presentations on Angelman Syndrome Program at ESGCT and NORD Rare Disease Summit

Agilis Biotherapeutics, Inc. (Agilis), a biotechnology company advancing innovative DNA therapeutics for rare genetic diseases that affect the central nervous system (CNS), announ...

Jerome Lejeune Foundation USA Celebrates Lucas, the First Gerber Baby with Down Syndrome

The Jerome Lejeune Foundation USA celebrates Gerber Products Company for selecting Lucas Warren as America’s cutest baby. As the winner of the Eighth Annual Gerber Photo Search, Lucas is unquestiona...

Foundation Fighting Blindness will provide up to $7.5 million in funding to develop ProQR’s candidate QR-421a for Usher syndrome type 2A

Foundation Fighting Blindness and ProQR enter into a partnership to develop QR-421a for Usher syndrome type 2A, targeting mutations in exon 13 of the causative USH2A gene. Foundation Fighting Blind...

What Exactly Happens in the Cells of People with Down’s Syndrome?

Researchers in Switzerland have taken a closer look at the cells of Down’s syndrome patients, with widespread changes in protein expression observed. Down’s syndrome, or trisomy 21, is the most co...

How to Get Over Impostor Syndrome as a New Graduate Student

You made it. You got into the grad school of your dreams! You worked hard, you spent hours working on your application, bravely navigated your way through the interview and you now are here. So, why d...

Drugs and Medications [450 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2581 Associated PubMed Articles listed on BioPortfolio]

Eye gaze and pupillary response in Angelman syndrome.

Angelman syndrome (AS) is a rare neurological disorder characterized by severe developmental disability, communication impairment, elevated seizure risk, and motor system abnormalities.

Sleep in children with Angelman syndrome: Parental concerns and priorities.

Angelman syndrome is a rare genetic syndrome, in which sleep disturbances are reported for 20-80% of individuals (Williams et al., 2006). This interview study delineated parental perceptions of sleep ...

Main causes of hospitalization in people with Angelman syndrome.

The objective was to describe the main causes of hospitalization in people with Angelman syndrome (AS).

Left ventricular dysfunction in a patient with Angelman syndrome.

Anesthesia considerations for an adult patient with Angelman syndrome.

Clinical Trials [3736 Associated Clinical Trials listed on BioPortfolio]

Study on the Brain Network of Angelman Syndrome

The aims of study on Angelman syndrome: (1)establish the Angelman syndrome database (2)to study the brain Network of Angelman Syndrome Based on Multi-modal Brain Image and Neural-EEG Data

Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome

This study is designed to determine the highest dose of levodopa/carbidopa that can be tolerated without any serious side effects by children with Angelman syndrome. It has been hypothesi...

Characterization of Angelman Syndrome

Angelman Syndrome (AS) is a developmental disorder that is caused by a deficiency of a maternally transmitted gene. It is inherited at birth, and affects movement, speech, and social demea...

Dietary Supplements for the Treatment of Angelman Syndrome

Angelman syndrome (AS) is a complex genetic disorder that affects the nervous system. The purpose of this study is to determine the effectiveness of certain dietary supplements in treating...

A Study in Adults With Angelman Syndrome

The purpose of the study is to assess the safety and tolerability of oral OV101 (gaboxadol) in adult subjects with Angelman syndrome. In addition, several exploratory efficacy outcome meas...

Companies [1462 Associated Companies listed on BioPortfolio]

Angelman Syndrome Foundation

Since 1996, the Angelman Syndrome Foundation has funded 59 research grants totaling more than $3.5 million. The Angelman Syndrome Foundation has awarded a majority of these funds ($3.3 million) beginn...

Foundation for Angelman Syndrome Therapeutics (FAST)

Angelman Syndrome (AS) was first described by Dr. Harry Angelman in 1965. Common symptoms include developmental delay and intellectual disabilities, happy demeanor, movement and balance disorder, seve...

The Angelman Syndrome Foundation

Sjogren's Syndrome Foundation

Founded in 1983, the Sjogren's Syndrome Foundation (SSF) provides patients with practical information and coping strategies that minimize the effects of Sjogren's syndrome. In addition, the Foundation...

Global Down Syndrome Foundation

The Global Down Syndrome Foundation is a public non-profit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, ed...

More Information about "The Angelman Syndrome Foundation" on BioPortfolio

We have published hundreds of The Angelman Syndrome Foundation news stories on BioPortfolio along with dozens of The Angelman Syndrome Foundation Clinical Trials and PubMed Articles about The Angelman Syndrome Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Angelman Syndrome Foundation Companies in our database. You can also find out about relevant The Angelman Syndrome Foundation Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record